Literature DB >> 9717719

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.

I Björkhem1, D Lütjohann, U Diczfalusy, L Ståhle, G Ahlborg, J Wahren.   

Abstract

We have previously demonstrated that the brain contains about 80% of the 24S-hydroxycholesterol in the human body and that there is a net flux of this steroid from the brain into the circulation (Lütjohann, D. et al. 1996. Proc. Natl. Acad. Sci. USA. 93: 9799-9804). Combining previous data with new data on 12 healthy volunteers, the arteriovenous difference between levels of this oxysterol in the internal jugular vein and in a peripheral artery was found to be -10.2 +/- 2.8 ng/ml (mean +/- SEM) corresponding to a net flux of 24S-hydroxycholesterol from the brain of about 6.4 mg/24 h. The arteriovenous difference between levels of 24S-hydroxycholesterol in the hepatic vein and a peripheral artery of 12 other volunteers was found to be 7.4 +/- 2.2 ng/ml, corresponding to a hepatic uptake of about 7.6 mg/24 h. The concentrations of 24S-hydroxycholesterol in the renal vein were about the same as those in a peripheral artery, indicating that a renal elimination is not of importance. Intravenously injected deuterium-labeled racemic 24-hydroxycholesterol was eliminated from the circulation of two human volunteers with half-lives of 10 h and 14 h, respectively. A positive correlation was found between the levels of circulating cholesterol and 24S-hydroxycholesterol. The results are consistent with a cerebral origin of most of the circulating 24S-hydroxycholesterol and suggest that the liver is the major eliminating organ. It is concluded that conversion into 24S-hydroxycholesterol is a quantitatively important mechanism for elimination of cholesterol from human brain. The possibility is discussed that circulating levels of 24S-hydroxycholesterol can be used as a marker for pathological and/or developmental changes in the brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717719

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  136 in total

Review 1.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

2.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

3.  Distribution of cholesterol 24-hydroxylase in the monkey brain.

Authors:  Xin He; Wei-Yi Ong; Qian Hua
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

4.  Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain.

Authors:  Emily D Salman; Ona Faye-Petersen; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2011-10

5.  Dietary intake of plant sterols stably increases plant sterol levels in the murine brain.

Authors:  Tim Vanmierlo; Oliver Weingärtner; Susanne van der Pol; Constanze Husche; Anja Kerksiek; Silvia Friedrichs; Eric Sijbrands; Harry Steinbusch; Marcus Grimm; Tobias Hartmann; Ulrich Laufs; Michael Böhm; Helga E de Vries; Monique Mulder; Dieter Lütjohann
Journal:  J Lipid Res       Date:  2012-01-25       Impact factor: 5.922

6.  Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Authors:  Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-31       Impact factor: 5.270

7.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

Review 8.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

Review 9.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

Review 10.  Fifty years of advances in bile acid synthesis and metabolism.

Authors:  David W Russell
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.